Study finds racial disparities in smoking cessation... ( A new study from the American Cancer...)

Study finds racial disparities in smoking cessation treatment

Date:4/24/2008

A new study from the American Cancer Society finds black and Hispanic smokers are less likely than whites to receive and use smoking cessation advice and aids. The study, published in the May issue of the American Journal of Preventive Medicine, also finds men and those without a usual source of medical care were less likely to be screened for tobacco use and receive advice to quit.

Members of several racial and ethnic minority populations bear a disproportionate share of the adverse health consequences of tobacco use. There is strong evidence that interventions, ranging from a health care workers brief advice to quit to extensive counseling and the use of pharmaceutical and behavioral adjuncts, can considerably improve cessation rates in smokers. Smoking is associated with socioeconomic disadvantage and is an important contributor to inequalities in health.

For their study, American Cancer Society researchers led by Vilma Cokkinides, Ph.D., analyzed survey results from 4756 smokers (aged 18 and older) who visited a healthcare provider within the past year. All were participants in the 2005 National Health Interview Survey (NHIS). The analysis found that compared to white smokers, black and Hispanic smokers were less likely to have been asked about tobacco use (85 percent in whites versus 77 percent in blacks and 72 percent in Hispanics); less likely to have been advised to quit (63 percent in whites versus 55 percent in blacks and 48 percent in Hispanics); and less likely to have used tobacco-cessation aids during the past year in a quit attempt (38 percent in whites versus 24 percent in blacks and 21 percent in Hispanics).These racial/ethnic differences in the use of smoking cessation remained significant even after controlling for various other factors (for example, health insurance coverage, or socio-economics status of smokers).

The good news is the number of smokers who are getting advice to quit is rising, from 53 percent in 2
'/>"/>

Contact: David Sampson
david.sampson@cancer.org
American Cancer Society
Source:Eurekalert

0

GOOD

Page: 1 2
Related medicine news :

1. Antipodean Pharmaceuticals Announces Results of Phase 2 Study of Lead Compound MitoQ(R)
2. Harvard Business School Publishes a Case Study on Robert Wessman and Actavis
3. Study finds that competency in colonoscopy requires experience with 150 cases or more
4. Study finds cisplatin less effective than standard treatment for patients with anal cancer
5. Potential viral therapy weapon for difficult cancers is safe and effective in study
6. Study: Counseling trauma victims causes secondary trauma
7. Rat study suggests why teens get hooked on cocaine more easily than adults
8. Study Shows Increased Out-of-Pocket Expenses May Negatively Influence Initiation of TNF Blocker Therapy
9. Teenage suicides: Study advocates greater family support
10. Cancer cells spread by releasing bubbles, according to an MUHC study
11. Many Cancer Survivors Are Overweight and Sedentary: Study

Post Your Comments:

(Date:5/21/2013)... 2013 Standard advice for mattress shoppers ... else. However given industry’s less than exceptional satisfaction ratings ... the internet, Consumer Mattress Reports sets out to revise ... Best Mattress .” , This article addresses several components ... that may not be readily apparent to many shoppers. ...

(Date:5/21/2013)... 2013 DISCcert has served the training ... use 17 DISC applications at the July 25 & ... , The July 25 & 26th DISC certification in ... of applying DISC. The time-tested, proven support materials will ... DISC training materials ; worksheets, handouts, learning ...

(Date:5/21/2013)... 2013 Parker Waichman LLP, a national ... injured by defective medical devices, is addressing new research ... on May 15, 2013. The study found that magnetic ... that occur in patients with metal-on-metal hip implants even ... ) , “We’ve known for quite ...

(Date:5/21/2013)... France: The Orsiro stent, which is a novel ... demonstrated non-inferiority to the Xience Prime everolimus-eluting stent ... lumen loss at nine months in the results ... today. , The BIOFLOW-II substudy used intravascular ultrasound ... assess neointimal hyperplasia and stent apposition at nine ...

(Date:5/21/2013)... (PRWEB) May 21, 2013 Phoseon Technology ... at the 20th Annual IMI European Ink Jet ... proven market leader, Phoseon continues to invest in product ... the adoption of UV LED curing in printing applications. ... families on the market offering both air cooled and ...

Breaking Medicine News(10 mins):Health News:Choosing the Best Mattress Simplified in Consumer Mattress Reports’ Latest Article 2 Health News:DISCcert Offers 17 Applications in Coming DISC Certification 2 Health News:DISCcert Offers 17 Applications in Coming DISC Certification 3 Health News:DISCcert Offers 17 Applications in Coming DISC Certification 4 Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 2 Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 3 Health News:Biodegradable stent proves non-inferior to drug-eluting stent 2

[0] Choosing the Best Mattress Simplified in Consumer Mattress Reports’ Latest Article [0] DISCcert Offers 17 Applications in Coming DISC Certification [0] Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants [0] Biodegradable stent proves non-inferior to drug-eluting stent [0] Phoseon Technology Presents the Leading UV LED Curing Solutions at IMI European Ink Jet Conference

... International Liver Congress 2009, the 44th annual meeting of the ... Journalist registrations are being accepted for International Liver Congress 2009, ... , Press registration is free of charge for all holders ... The official EASL press conference will be held from 13.15 ...

... A failing heart makes a lot of a hormone needed ... but not enough of the enzyme needed to activate it, ... College of Georgia researchers found people in heart failure have ... pro-atrial natriuretic peptide, a hormone made by heart muscle cells ...

... WASHINGTON, March 31 Jeffrey Levi, Ph.D., ... today before the U.S. House Energy and Commerce Committee,s ... Care Work for American Families: Protecting the Public Health." ... investing in prevention, and the importance of incorporating public ...

... March 31 The not-for-profit LENA Foundation ... Biennial Meeting of the Society of Research in Child ... Colorado, four talks and one poster will be presented ... http://www.newscom.com/cgi-bin/prnh/20090210/LA69114 )"This year,s SRCD is a great opportunity ...

... 31 /PRNewswire-FirstCall/ - Hard To Treat Diseases (HTDS) ... Award" is a most coveted, prestigious award, and ... Science and Technological Development. Submitted with the award ... preliminary trial of their Ribavirin product, confirming its ...

... March 31 Five local organizations and,individuals committed ... cholesterol,in Hispanic communities were awarded 2009 Cheerios Angel ... Chosen from a winning pool of nominations, ... healthier lifestyles and provided excellent resources to help ...

Cached Medicine News:Health News:New tests provide new insight into why patients are in heart failure 2 Health News:New tests provide new insight into why patients are in heart failure 3 Health News:Trust for America's Health Testifies before Congress on Building Prevention into Health Reform 2 Health News:Trust for America's Health Testifies before Congress on Building Prevention into Health Reform 3 Health News:Trust for America's Health Testifies before Congress on Building Prevention into Health Reform 4 Health News:Five Research Studies at International SRCD Meeting in Denver Use Technology from Boulder Foundation 2 Health News:Five Research Studies at International SRCD Meeting in Denver Use Technology from Boulder Foundation 3 Health News:Hard To Treat Diseases (HTDS) Best Technological Innovation Award 2009 2 Health News:Cheerios(R) Angel de mi Corazon Awards $25,000 to Those Who Fight Heart Disease and High Cholesterol in Hispanic Communities Across the U.S. 2 Health News:Cheerios(R) Angel de mi Corazon Awards $25,000 to Those Who Fight Heart Disease and High Cholesterol in Hispanic Communities Across the U.S. 3 Health News:Cheerios(R) Angel de mi Corazon Awards $25,000 to Those Who Fight Heart Disease and High Cholesterol in Hispanic Communities Across the U.S. 4

International Liver Congress 2009 New tests provide new insight into why patients are in heart failure Trust for America's Health Testifies before Congress on Building Prevention into Health Reform Five Research Studies at International SRCD Meeting in Denver Use Technology from Boulder Foundation Hard To Treat Diseases (HTDS) Best Technological Innovation Award 2009 Cheerios(R) Angel de mi Corazon Awards $25,000 to Those Who Fight Heart Disease and High Cholesterol in Hispanic Communities Across the U.S.

(Date:5/21/2013)... and TARRYTOWN, N.Y. , May ... SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced ... published online the positive Phase 2a study results of ... is an investigational monoclonal antibody targeting the alpha subunit ... signaling of both IL-4 and IL-13, drivers of Th2 ...

(Date:5/21/2013)... UNION CITY, Calif. , May 21, 2013 /PRNewswire/ ... manufacturing point-of-care blood analysis systems, announced today that ... will present at the Stifel Annual Dental & Veterinary ... ET. The conference will be held at Le Parker ... . About Abaxis Abaxis develops, ...

(Date:5/21/2013)... May 21, 2013 Reportlinker.com announces ... available in its catalogue: ... Scenario for Medical Devices in the US ... Changing Regulatory and Reimbursement ... Market Summary ...

Breaking Medicine Technology:Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 2 Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 3 Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 4 Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 5 Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 6 Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 7 Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2 Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 2 Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 3 Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 4

[0] Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine [0] Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference [0] Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market

... HIGHLIGHTS:2011 Results (all percentages are to ... reported sales increased 11% to $626 million. Q3 sales grew ... sales growing organically by 4% and 2%, respectively. Recently completed ... exchange rates contributed an additional 5% to reported sales growth ...

... Botanic Pharmaceutical Inc. (NYSE AMEX: CBP ) ... distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ... recently hosted a technical exchange between 13 senior research ... and herbal medicine. China Botanic participated ...

Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81.China Botanic Hosts Technical Exchange for Industry Research Experts

A gentle yet highly effective corneal rust ring remover with Alger brush of 1mm burr. Runs off 1 x AA battery, no switches, simply spin mandrel to operate....

Foreign body removal system. Designed to aid in the removal of foreign bodies and corneal rust rings....

Foreign body removal system. Designed to aid in the removal of foreign bodies and corneal rust rings. Ophtho-burr handpiece only. Battery powered handpiece....

Katena ophthalmic burr for polishing pterygiums, includes one round diamond burr and has an storage case....

Medicine Products:

Alger Brush Mk II Diamond Burr 2.5mm (5085)Ophtho-Burr Katena Ophthalmic Burr